Skip to main content
Equibles
HUM logo

HUM · Humana Inc · Documents

Track HUM — free

Use HUM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HUM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$411.79 -5.63 (-1.35%) At close · Nov 5 Earnings today Play latest call Q2 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$50.12B
Shares
120.06M
Volume · Nov 5 1.36M Avg daily vol (3M) 1.25M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $129.66B up 10.1% 10-K filed Feb 19, 2026 Quarterly report FY2026 Q2 Revenue $40.87B up 26.2% 10-Q filed Jul 29, 2026 Latest results Financial results 8-K filed Jul 29, 2026 Earnings call Q2 2026 earnings call Held Jul 29, 2026
2026
Oct 13
Current report 8-K
Regulation FD disclosure

Humana entered a majority-owned BlackRock joint venture managing nearly 150 CenterWell Senior Primary Care clinics, replacing existing joint ventures and expected to reduce liabilities and cost of capital. Humana affirmed FY 2026 adjusted EPS guidance of at least $9.00.

Oct 9
Current report 8-K
Regulation FD disclosure

Humana Inc. says final 2027 Medicare Advantage Star Ratings data show it exceeded its Top Quartile goal, expects a one-time 2028 benefit for one-time investments and shareholder returns, and affirms at least $9.00 adjusted EPS for FY 2026.

Jul 29
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $40.87B ▲ 26.2% Net income $694M ▲ 27.3% Diluted EPS $5.73 ▲ 27.1%
Apr 29
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $39.65B ▲ 23.5% Net income $1.19B ▼ 4.7% Diluted EPS $9.83 ▼ 4.6%
Mar 6
Proxy statement DEF 14A Meeting Apr 16, 2026
Proxy statement AI summary on its way
Feb 19
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $129.66B ▲ 10.1% Net income $1.19B ▼ 1.6% Diluted EPS $9.84 ▼ 1.4%
2025
Nov 5
Quarterly report 10-Q FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $32.65B ▲ 11.1% Net income $195M ▼ 59.4% Diluted EPS $1.62 ▼ 59.3%
Jul 30
Quarterly report 10-Q FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $32.39B ▲ 9.6% Net income $545M ▼ 19.7% Diluted EPS $4.51 ▼ 19.8%
Apr 30
Quarterly report 10-Q FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $32.11B ▲ 8.4% Net income $1.24B ▲ 67.9% Diluted EPS $10.30 ▲ 68.6%
Feb 20
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $117.76B ▲ 10.7% Net income $1.21B ▼ 51.5% Diluted EPS $9.98 ▼ 50.1%
2024
Showing 1–50 of 198 documents
Key facts CIK 49071 CUSIP 444859102 13F (30d) 433 filings 394 filers Visit website Investor relations